BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Adipose tissue
,
Anticancer prodrugs
,
Phenobarbital
,
rs3825942
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NGR
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cerebellum
Cerebellar hemisphere
Temporal lobe
Cerebellar vermis
Frontal lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Q fever
Brucellosis
Tinea pedis
Herpesvirus infection
Lyme disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
HX 630
Antibodies, Anti-DNA
Platelet-Derived Growth Factor
piperlonguminine
potassium chromate(VI)
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CARMN
PUM1
TARBP2P1
BAG1
DPRX
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Molecular Characterization and Function of the Nogo-66 Receptor (NgR1) Gene in the Chinese Tree Shre…
Fasudil reduces apoptosis of SH-SY5Y cells induced by H2O2 and promotes synaptic plasticity by inhib…
The Nogo-66 Receptors NgR1 and NgR3 Are Required for Commissural Axon Pathfinding.
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2.
Nogo receptor impairs the clearance of fibril amyloid-β by microglia and accelerates Alzheimer's-lik…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarco…
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural M…
Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ